Cefuroxime 500 MG + Clav 125 MG Tabs

Cefuroxime 500 MG + Clav 125 MG Tabs is a tablet composition made of Cefuroxime and Clavulanic Acid and a strong product that stands out in the antibiotic section. Pharmaceutical organizations commonly add this type of tablet formulation in their product portfolios. By combining Cefuroxime 500 mg with Clav 125 mg, this formulation is well known in the general medicine and prescription-based products.

This combination formulation is available in the tablet form and that makes it easier to package, stock, supply and distribute via various pharma channels. It is considered a must have product for those organizations working in the antibiotic, general medicine, and PCD pharma franchise business segments. With good manufacturing standards and suitable packaging the Cefuroxime 500 MG + Clav 125 MG Tabs can really prove to be a quality addition in a professional pharma product range.

Composition Profile and Strength of Formulation

The Cefuroxime 500 MG + Clav 125 MG Tabs contain 500mg of Cefuroxime and 125mg of Clavulanic Acid per tablet as the main active ingredients. While the formulation's component Cefuroxime belongs to the cephalosporin group the Clavulanic acid component adds to the product’s formulation profile. Together they constitute a combination widely recognized in the pharmaceutical marketplace.

This tablet's strength of 500 mg and 125 mg makes it an extremely strong market presence among the same product class. This composition is normally manufactured along with necessary excipients that can maintain tablet quality, hardness, stability, disintegration, and shelf-life. A quality formulated product is likely to consist of similar composition throughout the entire manufacturing lot.

Quality Manufacturing & Standard Processing

The quality manufacturing of Cefuroxime 500 MG + Clav 125 MG Tabs involves rigorous production procedures and consistent quality controls. Credible organizations manufacture these tablets by using premium raw materials and innovative machinery to maintain purity, strength, and stability of the finished product. Every process of manufacturing is performed in a clean and controlled environment to yield pharmaceutical standard quality products.

Quality checks at various manufacturing stages are imperative in order to maintain the desired output. Raw material testing, in-process controls, tablet compression inspection, coating, finished product testing and finally, packaging quality checks are all included in the standard process of producing the pharmaceutical product. Since this is a combination formulation it becomes essential to carefully check the proportion of the two active ingredients blended together in the same tablet.

Packaging, Labeling & Brand Presentation

Packaging provides a protective casing for the Cefuroxime 500 MG + Clav 125 MG Tabs and also helps it attain a better visual presence. This composition usually gets packaged in blister or alu-alu packaging or even strips depending on the company’s preference. A robust packaging system can effectively protect the tablet from elements such as moisture, air, and sunlight.

The product label must clearly state all the essential information such as, brand name, salt names, strength, batch number, manufacturing & expiry date, MRP, storage conditions, etc. The information printed in the product should be clean and easily legible. In order to make the product attractive, unique, and professional, smart color combinations can be incorporated into the label.

For pharma companies it is important to make the product as distinctive as possible. Strips that are neatly designed, along with well-presented cartons can play an effective role in creating a brand identity and improving product recall amongst target customers and physicians.

Market Demand & Business Importance

Cefuroxime 500 MG + Clav 125 MG Tabs are very much in demand in the pharmaceutical market due to its recognized composition and established presence in the antibiotic section of products. This is why the medicine is present in almost all of the medical catalogues of pharma companies engaged in the general medicine and franchise business model.

This product has high business importance for distributors, wholesalers, retailers and PCD pharma franchise partners. Most companies have a strong portfolio that must consist of antibiotic products which are highly sought after. By stocking and distributing this formulation in their distribution network these parties are assured of a consistently demanded product and a better return on their investment.

Companies who are looking to add a variety of high-demand compositions to their pharma products can be assured that Cefuroxime 500 MG + Clav 125 MG Tabs would make a sound addition to their inventory if well formulated and properly manufactured.

PCD Pharma Franchise Scope

Cefuroxime 500 MG + Clav 125 MG Tabs is an ideal product to distribute in a PCD pharma franchise business. The product belongs to the competitive and much sought after antibiotic category. The marketing of such a product would involve providing visual aids, product cards, reminder cards, MR bags, prescription pads etc. To the distributors and partners.

By including this product in the territory provided to the PCD franchise partners, the companies would not only add a significant antibiotic formulation to the distribution segment but would also ensure wider market penetration. A good quality and reliable supply backed up with a unique brand identity and attractive offer for franchise partners could be the right choice for the PCD pharma business.

Its excellent formulation strength, quality of manufacturing, and constant market demand makes it a trustworthy and worthwhile product for pharmaceutical businesses.